loadpatents
Patent applications and USPTO patent grants for GLAESNER; Wolfgang.The latest application filed is for "use of an fgf-21 compound and a glp-1 compound for the treatment of obesity".
Patent | Date |
---|---|
Use Of An Fgf-21 Compound And A Glp-1 Compound For The Treatment Of Obesity App 20140024586 - COSKUN; Tamer ;   et al. | 2014-01-23 |
Co-administration of FGF-21 and GLP-1 to treat diabetes and lower blood glucose Grant 8,557,769 - Coskun , et al. October 15, 2 | 2013-10-15 |
Use Of An Fgf-21 Compound And A Glp-1 Compound For The Treatment Of Obesity App 20120264683 - Coskun; Tamer ;   et al. | 2012-10-18 |
GLP-1 analog fusion proteins Grant 8,273,854 - Glaesner , et al. September 25, 2 | 2012-09-25 |
GLP-1 pegylated compounds Grant 8,183,340 - Glaesner , et al. May 22, 2 | 2012-05-22 |
Use Of An Fgf-21 Compound And A Glp-1 Compound For The Treatment Of Obesity App 20110034373 - Coskun; Tamer ;   et al. | 2011-02-10 |
Glp-1 Analog Fusion Protein Formulations App 20090232807 - Glaesner; Wolfgang ;   et al. | 2009-09-17 |
Glp-1 Pegylated Compounds App 20090215981 - Glaesner; Wolfgang ;   et al. | 2009-08-27 |
FGF-21 fusion proteins Grant 7,576,190 - Glaesner , et al. August 18, 2 | 2009-08-18 |
Polyethylene glycol linked GLP-1 compounds Grant 7,557,183 - DiMarchi , et al. July 7, 2 | 2009-07-07 |
Muteins Of Fibroblast Growth Factor 21 App 20090118190 - Beals; John Michael ;   et al. | 2009-05-07 |
Glp-1 Analog Fusion Proteins App 20090074769 - Glaesner; Wolfgang ;   et al. | 2009-03-19 |
Method of treating a subject suffering stroke comprising administering Glucagon-like peptide-1 analogs Grant 7,498,308 - Glaesner , et al. March 3, 2 | 2009-03-03 |
Muteins of fibroblast growth factor 21 Grant 7,491,697 - Beals , et al. February 17, 2 | 2009-02-17 |
Extended glucagon-like peptide-1 analogs Grant 7,482,321 - Glaesner , et al. January 27, 2 | 2009-01-27 |
GLP-1 analog fusion proteins Grant 7,452,966 - Glaesner , et al. November 18, 2 | 2008-11-18 |
Selective Vpac2 Receptor Peptide Agonists App 20080096811 - Bokvist; Bengt Krister ;   et al. | 2008-04-24 |
Selective Vpac2 Receptor Reptide Agonists App 20080026996 - Bokvist; Bengt Krister ;   et al. | 2008-01-31 |
Glycol Linked Fgf-21 Compounds App 20070265200 - Glaesner; Wolfgang ;   et al. | 2007-11-15 |
Fusion Proteins App 20070253966 - Glaesner; Wolfgang ;   et al. | 2007-11-01 |
Fgf-21 Fusion Proteins App 20070237768 - Glaesner; Wolfgang ;   et al. | 2007-10-11 |
GLP-1 fusion proteins Grant 7,271,149 - Glaesner , et al. September 18, 2 | 2007-09-18 |
Glp-1 Fusion Proteins App 20070161087 - Glaesner; Wolfgang ;   et al. | 2007-07-12 |
Muteins of fibroblast growth factor 21 App 20070142278 - Beals; John Michael ;   et al. | 2007-06-21 |
Erythropoietic compounds App 20070100133 - Beals; John Michael ;   et al. | 2007-05-03 |
Amidated glucagon-like peptide-1 Grant 7,199,217 - DiMarchi , et al. April 3, 2 | 2007-04-03 |
Glp-1 analog fusion proteins App 20070036806 - Glaesner; Wolfgang ;   et al. | 2007-02-15 |
Glucagon-like peptide-1 analogs App 20060263849 - Glaesner; Wolfgang ;   et al. | 2006-11-23 |
Glucagon-like peptide-1 analogs App 20060252693 - Glaesner; Wolfgang ;   et al. | 2006-11-09 |
Glucagon-like peptide-1 analogs Grant 7,101,843 - Glaesner , et al. September 5, 2 | 2006-09-05 |
Glucagon-like peptide-1 analogs Grant 7,084,243 - Glaesner , et al. August 1, 2 | 2006-08-01 |
Extended glucagon-like peptide-1 analogs App 20060014241 - Glaesner; Wolfgang ;   et al. | 2006-01-19 |
Glucagon-like peptide-1analogs App 20040198654 - Glaesner, Wolfgang ;   et al. | 2004-10-07 |
Amidated glucagon-like peptide-1 App 20040132647 - DiMarchi, Richard Dennis ;   et al. | 2004-07-08 |
GLP-1 Fusion Proteins App 20040053370 - Glaesner, Wolfgang ;   et al. | 2004-03-18 |
Glucagon-like peptide-1 analogs App 20030220243 - Glaesner, Wolfgang ;   et al. | 2003-11-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.